New Haven, CT’s HistoRx, which is developing tissue-based diagnostics, announced it has closed a $6 million Series B funding round. The deal was led by Brook Venture Partners, and joined by Navigator Technology Ventures, The Roche Venture Fund, Commons Capital, and Maven Capital.
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom
